Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis
2021-03-17 20:00
VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update
2021-03-16 20:30
VolitionRx Limited to Present at Conferences in March 2021
2021-03-09 05:15
VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock
2021-02-12 22:25
VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
2021-02-10 22:18
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts
2021-02-02 20:45
VolitionRx Limited Opens its New Manufacturing Facility in Belgium
2021-01-25 21:45
VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding
2021-01-06 21:25
VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors
2020-12-03 21:30
Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S.
2020-12-01 21:45
VolitionRx Limited to Present COVID-19 Data at MEDICA 2020
2020-11-19 20:00
Volition Veterinary Presents Expert Report Ahead of First Product Launch
2020-11-10 21:00
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update
2020-11-09 21:00
VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020
2020-10-21 20:00
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
2020-10-20 19:00
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference
2020-10-16 20:00
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
2020-10-14 20:00
Volition Veterinary Diagnostics Development LLC to Present Product Data Regarding its Nu.Q™ Vet Cancer Screening Test at the 2020 VCS Virtual Annual Conference
2020-10-12 20:00
VolitionRx Limited Announces Virtual Capital Markets Day 2020
2020-09-29 20:00
VolitionRx Limited to Present at Conferences in September 2020
2020-09-01 20:00
1
2
3
4
5
7